Featured Research

from universities, journals, and other organizations

Simple test can detect signs of suicidal thoughts in people taking antidepressants

Date:
April 11, 2010
Source:
University of California - Los Angeles
Summary:
Researchers have developed a non-invasive biomarker, or indicator, using a non-invasive measurement of electrical activity in the brain, to associate a sharp reduction of activity in a specific brain region within 48 hours of beginning pharmaceutical treatment in people who proved susceptible to developing thoughts of suicide.

Brain images from individuals who developed thoughts of suicide (left) and those who did not; the blue indicates a decrease in activity. Changes in brain activity as measured by QEEG. The blue color on the left shows the greatest decrease in brain activity in the midline and right frontal region of the patients who experienced thoughts of suicide.
Credit: Image courtesy of University of California - Los Angeles

While antidepressant medications have proven to be beneficial in helping people overcome major depression, it has long been known that a small subset of individuals taking these drugs can actually experience a worsening of mood, and even thoughts of suicide. No clinical test currently exists to make this determination, and only time -- usually weeks -- can tell before a psychiatrist knows whether a patient is getting better or worse.

Now, UCLA researchers have developed a non-invasive biomarker, or indicator, that may serve as a type of early warning system.

Reporting in the April edition of the peer-reviewed journal Acta Psychiatrica Scandinavica, Aimee Hunter, an assistant research psychologist in the UCLA Department of Psychiatry, and colleagues report that by using quantitative electroencephalographic (QEEG), a non-invasive measurement of electrical activity in the brain, they were able to observe a sharp reduction of activity in a specific brain region in individuals who proved susceptible to thoughts of suicide -- within 48 hours of the start of treatment.

Prior research, Hunter said, has shown that between 8 and 14 percent of depressed patients develop thoughts of suicide while taking the most common forms of depression drugs, known as selective serotonin reuptake inhibitors (SSRI). Although reports have suggested that SSRIs are to blame, no firm link between these drugs and thoughts of suicide has been established.

This study suggests, for the first time, a link between worsening suicidality and specific changes in brain function while on these medications.

The researchers treated 72 people suffering from major depressive disorder (MDD) with one of two SSRIs, fluoxetine or venlafaxine, or with a placebo. All were evaluated by a clinician using the Hamilton Depression Rating Scale, a standard instrument that assesses the severity of a wide range of depression symptoms. Of the 37 participants on medication, five (13.5 percent) had worsening thoughts of suicide.

All of the participants were also examined using QEEG, which evaluates brain function based on the brain's electrical activity. Among the 13.5 percent of participants who got worse, the researchers found a sharp drop in brain activity within 48 hours of the start of medication. The drop occurred in the midline and right-frontal sections of the brain, areas known to control emotions.

Of note, eight of the 35 participants taking a placebo (22.9 percent) also had increased thoughts of suicide. However, the placebo participants did not show the precipitous drop in brain activity within the first 48 hours.

"This is the first study to show a change in brain function after the start of medication that appears to be linked to the subsequent development of worsening thoughts of suicide during antidepressant treatment," Hunter said. "Importantly, changes in this biomarker did not predict worsening suicidal thoughts in the placebo-treated subjects, so the results suggest that the biomarker specifically detected medication-related worsening only."

QEEG is a relatively inexpensive instrument that is non-invasive; measurements are obtained by placing electrodes on the scalp. As a result, Hunter said, further development of this biomarker could potentially lead to a tool that could be used by clinicians to predict, in the early stages of treatment, whether an individual suffering from depression will develop thoughts of suicide.

Other authors of the study included Andrew Leuchter, Ian Cook and Michele Abrams, all of UCLA.

Funding for the study was provided by the National Institute of Mental Health; the National Center for Complementary and Alternative Medicine; grants from Lilly Research Laboratories, Wyeth Pharmaceuticals and Aspect Medical Systems; and an endowment from Joanne and George Miller and family to the UCLA Brain Research Institute. The funding providers had no role in any aspect of the study.


Story Source:

The above story is based on materials provided by University of California - Los Angeles. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. M. Hunter, A. F. Leuchter, I. A. Cook, M. Abrams. Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta Psychiatrica Scandinavica, 2010; DOI: 10.1111/j.1600-0447.2010.01560.x

Cite This Page:

University of California - Los Angeles. "Simple test can detect signs of suicidal thoughts in people taking antidepressants." ScienceDaily. ScienceDaily, 11 April 2010. <www.sciencedaily.com/releases/2010/04/100409093411.htm>.
University of California - Los Angeles. (2010, April 11). Simple test can detect signs of suicidal thoughts in people taking antidepressants. ScienceDaily. Retrieved September 15, 2014 from www.sciencedaily.com/releases/2010/04/100409093411.htm
University of California - Los Angeles. "Simple test can detect signs of suicidal thoughts in people taking antidepressants." ScienceDaily. www.sciencedaily.com/releases/2010/04/100409093411.htm (accessed September 15, 2014).

Share This



More Mind & Brain News

Monday, September 15, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Shocker: Journalists Are Utterly Addicted To Coffee

Shocker: Journalists Are Utterly Addicted To Coffee

Newsy (Sep. 13, 2014) A U.K. survey found that journalists consumed the most amount of coffee, but that's only the tip of the coffee-related statistics iceberg. Video provided by Newsy
Powered by NewsLook.com
'Magic Mushrooms' Could Help Smokers Quit

'Magic Mushrooms' Could Help Smokers Quit

Newsy (Sep. 11, 2014) In a small study, researchers found that the majority of long-time smokers quit after taking psilocybin pills and undergoing therapy sessions. Video provided by Newsy
Powered by NewsLook.com
'Fat Shaming' Might Actually Cause Weight Gain

'Fat Shaming' Might Actually Cause Weight Gain

Newsy (Sep. 11, 2014) A study for University College London suggests obese people who are discriminated against gain more weight than those who are not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins